" /> Fetal trisomy 13 risk:Likelihood:Pt:Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA - CISMeF





Preferred Label : Fetal trisomy 13 risk:Likelihood:Pt:Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA;

LOINC status : ACTIVE;

LOINC display name : Trisomy 13 risk Dosage of chromosome-specific cfDNA Qn (cfDNA);

LOINC long common name : Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA;

LOINC short name : Fet Ts 13 risk Plas.cfDNA Qn;

LOINC description : The probability risk for trisomy 13 can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal sex chromosome aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
26/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.